Table 3.
Model | Factor | Comparison | Hazard Ratio | 95% LCL | 95% UCL | Overall p-value |
---|---|---|---|---|---|---|
RFS Model 1 (N = 706, #Events = 319) | Ki67% weighted average | >=5% vs. <5% | 1.471 | 1.110 | 1.950 | 0.0007 |
Margin | Pos vs. Neg | 1.598 | 1.248 | 2.047 | 0.0002 | |
Seminal vesicle invasion | Yes vs. No | 2.072 | 1.430 | 3.002 | 0.0001 | |
Gleason score | 3+4 vs. 6 | 1.297 | 0.972 | 1.732 | 0.004 | |
4+3 vs. 6 | 1.808 | 1.273 | 2.568 | |||
8–10 vs. 6 | 1.626 | 1.126 | 2.348 | |||
Log(PSA) | 1 unit increase | 1.536 | 1.288 | 1.831 | <.0001 | |
RFS Model 2 (N = 706, #Events = 319) | Ki67% maximum | >=5% vs. <5% | 1.314 | 1.033 | 1.672 | 0.03 |
Margin | Pos vs. Neg | 1.596 | 1.246 | 2.043 | 0.0002 | |
Seminal vesicle invasion | Yes vs. No | 2.119 | 1.462 | 3.070 | <.0001 | |
Gleason score | 3+4 vs. 6 | 1.317 | 0.986 | 1.757 | 0.0002 | |
4+3 vs. 6 | 1.876 | 1.324 | 2.658 | |||
8–10 vs. 6 | 1.670 | 1.159 | 2.406 | |||
Log(PSA) | 1 unit increase | 1.505 | 1.264 | 1.792 | <.0001 |
Recurrence free survival (RFS) event is defined as any recurrence, metastasis, or prostate cancer death. Models 1 and 2 are separate models using Ki67 weighted average % positive (PI=2.19) and maximum % positive (PI=3.11), respectively. Only significant factors were included in the final models.